• Fri, November 18, 2016

by: WOPRAI

MaxLinear Inc. (NYSE:MXL), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

QuinStreet Inc. (NASDAQ:QNST), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Community West Bancshares (NASDAQ:CWBC), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In O

by: WOPRAI

Piper Jaffray Companies (NYSE:PJC), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re

by: WOPRAI

Peoples Financial Services Corp (NASDAQ:PFIS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outline

by: WOPRAI

Scripps Networks Interactive Inc. (NASDAQ:SNI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Ou

by: WOPRAI

Amaya Inc. (NASDAQ:AYA), Up By $0.76 (5.03%) After BUYINS.NET SqueezeTrigger Report Released on Monday, November 14th 2016 at a

by: WOPRAI

Willdan Group Inc. (NASDAQ:WLDN), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Repo

by: WOPRAI

Acorda Therapeutics, Inc. (NASDAQ:ACOR), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In O

by: WOPRAI

PharmaCyte Biotech Inc. (OTC:PMCB), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re

by: WOPRAI

Ross Stores Inc. (NASDAQ:ROST), Up By $7.32 (11.94%) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 4th 20

by: WOPRAI

Cemex S.A.B. de C.V. (NYSE:CX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Sykes Enterprises Incorporated (NASDAQ:SYKE), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined

by: WOPRAI

Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG), Down After BUYINS.NET Report Predicted Stoc

by: WOPRAI

Gevo Inc. (NASDAQ:GEVO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

MADALENA ENERGY (OTC:MDLNF), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

American Public Education, Inc. (NASDAQ:APEI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Out

by: WOPRAI

Spark Therapeutics Inc. (NASDAQ:ONCE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

Pedevco Corp (NYSE:PED), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions

by: WOPRAI

NCIT SqueezeTrigger Price is $13.08. There is $1,207,170 That Short Sellers Still Need To Cover.

by: WOPRAI

PRSS, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

FMBH, IMH, GRC, BZH, RLI, ITCI, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

RUBI, TWOU, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

ATRA, MDSO, JMBA, ASCMA, ZNGA, TLYS, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

ZION, CAKE, PLXS, RARE, CORT, MGPI, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

GS, NCI, CCRN, SWKS, MRTN, NUAN, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

EPAY, VRA, FNSR, PBCT, WSBC, GBCI, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

DOG, AMJ, TYO, SEMG, GJR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

NCMI, LULU, WBC, ULTA, QLD, WWD Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

HOFT, DTSI, IRBT, CYNO, KALU, AYR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

BPFH, BABY, MPWR, CCMP, COST, ALGN Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SPR, RSP, RDWR, IJS, PRSC, LGND Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

INFN, FLIC, MON, CHFC, SNN, GPN Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CPB Expected To Be Down Before Next Earnings Releases

by: WOPRAI

James Fotheringham Downgraded (WRLD) to Sell and Held Target at $44 on, Nov 18th, 2016

by: WOPRAI

James Fotheringham Downgraded (WFC) to Sell and Held Target at $47 on, Nov 18th, 2016

by: WOPRAI

Fadi Chamoun Initiated (UPS) at Buy and Held Target at $125 on, Nov 18th, 2016

by: WOPRAI

Kevin Crissey Initiated (UAL) at Hold and Held Target at $69 on, Nov 18th, 2016

by: WOPRAI

Ronald Epstein Downgraded (BWXT) to Hold on, Nov 18th, 2016

by: WOPRAI

Angie Storozynski Initiated (ATO) at Strong Buy on, Nov 18th, 2016

by: WOPRAI

Debjit Chattopadhyay Initiated (VRTX) at Hold and Held Target at $98 on, Nov 18th, 2016

by: WOPRAI

Aaron Rakers Initiated (ANET) at Strong Buy and Held Target at $26 on, Nov 18th, 2016

by: WOPRAI

Kevin Crissey Initiated (ALK) at Hold and Held Target at $81 on, Nov 18th, 2016

by: WOPRAI

Kevin Crissey Initiated (ALGT) at Strong Buy and Held Target at $185 on, Nov 18th, 2016

by: WOPRAI

Ronald Epstein Upgraded (BAH) to Strong Buy on, Nov 18th, 2016

by: WOPRAI

Kevin Crissey Initiated (AAL) at Strong Buy and Held Target at $55 on, Nov 18th, 2016

by: WOPRAI

Laurie Havener Downgraded (BHLB) to Strong Sell on, Nov 18th, 2016

Debjit Chattopadhyay Initiated (VRTX) at Hold and Held Target at $98 on, Nov 18th, 2016

Debjit Chattopadhyay of Janney Montgomery Scott, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $98 on, Nov 18th, 2016.

Debjit has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 2 agree with Debjit's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
  • Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016


These are the ratings of the 2 analyists that currently disagree with Debjit

  • Biren Amin of "Jefferies" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, October 5th, 2016
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016

Like: 👍